Epidemiologic Characteristics of SARS-CoV-2 Recombinant Variant XBB.1.5-New York City, November 1, 2022-January 4, 2023

被引：0
|
作者：
Luoma, Elizabeth [1 ]
Rohrer, Rebecca [1 ]
Parton, Hilary [1 ]
Hughes, Scott [1 ]
Omoregie, Enoma [1 ]
Taki, Faten [1 ]
Wang, Jade C. [1 ]
Akther, Saymon [1 ]
Amin, Helly [1 ]
Chang, Carolyn [1 ]
Cheng, Iris [1 ]
Di Lonardo, Steve [1 ]
Eddy, Meredith [1 ]
Firestein, Lauren [1 ]
Li, Wenhui [1 ]
Su, Michelle [1 ]
Lee, Ellen H. [1 ]
机构：
[1] New York City Dept Hlth & Mental Hyg, Long Isl City, NY 11101 USA
来源：
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT | 2023年 / 72卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：212 / 214
页数：3
相关论文
共 50 条
  • [1] Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant
    Tomokazu Tamura
    Takashi Irie
    Sayaka Deguchi
    Hisano Yajima
    Masumi Tsuda
    Hesham Nasser
    Keita Mizuma
    Arnon Plianchaisuk
    Saori Suzuki
    Keiya Uriu
    Mst Monira Begum
    Ryo Shimizu
    Michael Jonathan
    Rigel Suzuki
    Takashi Kondo
    Hayato Ito
    Akifumi Kamiyama
    Kumiko Yoshimatsu
    Maya Shofa
    Rina Hashimoto
    Yuki Anraku
    Kanako Terakado Kimura
    Shunsuke Kita
    Jiei Sasaki
    Kaori Sasaki-Tabata
    Katsumi Maenaka
    Naganori Nao
    Lei Wang
    Yoshitaka Oda
    Terumasa Ikeda
    Akatsuki Saito
    Keita Matsuno
    Jumpei Ito
    Shinya Tanaka
    Kei Sato
    Takao Hashiguchi
    Kazuo Takayama
    Takasuke Fukuhara
    Nature Communications, 15
  • [2] Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant
    Tamura, Tomokazu
    Irie, Takashi
    Deguchi, Sayaka
    Yajima, Hisano
    Tsuda, Masumi
    Nasser, Hesham
    Mizuma, Keita
    Plianchaisuk, Arnon
    Suzuki, Saori
    Uriu, Keiya
    Begum, Mst Monira
    Shimizu, Ryo
    Jonathan, Michael
    Suzuki, Rigel
    Kondo, Takashi
    Ito, Hayato
    Kamiyama, Akifumi
    Yoshimatsu, Kumiko
    Shofa, Maya
    Hashimoto, Rina
    Anraku, Yuki
    Kimura, Kanako Terakado
    Kita, Shunsuke
    Sasaki, Jiei
    Sasaki-Tabata, Kaori
    Maenaka, Katsumi
    Nao, Naganori
    Wang, Lei
    Oda, Yoshitaka
    Sawa, Hirofumi
    Kawabata, Ryoko
    Watanabe, Yukio
    Sakamoto, Ayaka
    Yasuhara, Naoko
    Suzuki, Tateki
    Nakajima, Yukari
    Ferdous, Zannatul
    Shishido, Kenji
    Mugita, Yuka
    Takahashi, Otowa
    Ichihara, Kimiko
    Kaku, Yu
    Misawa, Naoko
    Guo, Ziyi
    Hinay, Alfredo, Jr.
    Kosugi, Yusuke
    Fujita, Shigeru
    Tolentino, Jarel M.
    Chen, Luo
    Pan, Lin
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [3] Emergence and dissemination of SARS-CoV-2 XBB.1.5 in New York
    Gambaro, Fabiana
    Duerr, Ralf
    Dimartino, Dacia
    Marier, Christian
    Iturrate, Eduardo
    Mulligan, Mark J.
    Heguy, Adriana
    Dellicour, Simon
    VIRUS EVOLUTION, 2024, 10 (01)
  • [4] Rapid Emergence and Epidemiologic Characteristics of the SARS-CoV-2 B.1.526 Variant - New York City, New York, January 1-April 5, 2021
    Thompson, Corinne N.
    Hughes, Scott
    Ngai, Stephanie
    Baumgartner, Jennifer
    Wang, Jade C.
    McGibbon, Emily
    Devinney, Katelynn
    Luoma, Elizabeth
    Bertolino, Daniel
    Hwang, Christina
    Kepler, Kelsey
    Del Castillo, Cybill
    Hopkins, Melissa
    Lee, Henry
    DeVito, Andrea K.
    Rakeman, Jennifer L.
    Fine, Anne D.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (19): : 712 - 716
  • [5] Reproduction number of SARS-CoV-2 Omicron variants, China, December 2022-January 2023
    Bai, Yuan
    Shao, Zengyang
    Zhang, Xiao
    Chen, Ruohan
    Wang, Lin
    Ali, Sheikh Taslim
    Chen, Tianmu
    Lau, Eric H. Y.
    Jin, Dong-Yan
    Du, Zhanwei
    JOURNAL OF TRAVEL MEDICINE, 2023, 30 (05)
  • [6] SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022 and 2023
    Lustig, Yaniv
    Canetti, Michal
    Indenbaum, Victoria
    Peretz, Yovel
    Weiss-Ottolenghi, Yael
    Margalit, Ili
    Asraf, Keren
    Levin, Tal
    Zuckerman, Neta
    Tomer, Enosh
    Mandelboim, Michal
    Doolman, Ram
    Barda, Noam
    Regev-Yochay, Gili
    EMERGING INFECTIOUS DISEASES, 2024, 30 (05) : 1050 - 1052
  • [7] Genomic surveillance of SARS-CoV-2 in mainland China after ending the zero-COVID policy, December 2022-January 2023
    Liu, Pengcheng
    Xu, Jin
    JOURNAL OF INFECTION, 2023, 86 (04) : E84 - E86
  • [8] SARS-CoV-2 dynamics in New York City during March 2020–August 2023
    Wan Yang
    Hilary Parton
    Wenhui Li
    Elizabeth A. Watts
    Ellen Lee
    Haokun Yuan
    Communications Medicine, 5 (1):
  • [9] Introduction and Establishment of SARS-CoV-2 Gamma Variant in New York City in Early 2021
    Vasylyeva, Tetyana, I
    Fang, Courtney E.
    Su, Michelle
    Havens, Jennifer L.
    Parker, Edyth
    Wang, Jade C.
    Zeller, Mark
    Yakovleva, Anna
    Hassler, Gabriel W.
    Chowdhury, Moinuddin A.
    Andersen, Kristian G.
    Hughes, Scott
    Wertheim, Joel O.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (12): : 2142 - 2149
  • [10] Genomic and epidemiological report of the recombinant XJ lineage SARS-CoV-2 variant, detected in northern Finland, January 2022
    Lindh, Erika
    Smura, Teemu
    Blomqvist, Soile
    Liitsola, Kirsi
    Vauhkonen, Hanna
    Savolainen, Laura
    Ikonen, Jaana
    Ronkainen, Jukka
    Taskila, Jyri
    Taskila, Tea
    Sakaranaho, Pertti
    Savolainen-Kopra, Carita
    Vapalahti, Olli
    Ikonen, Niina
    EUROSURVEILLANCE, 2022, 27 (16)
12345